QUEBEC CITY and MYRTLE BEACH, FL, Nov. 27, 2017 /CNW Telbec/ - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of Mr. Jean Lamarre, a member of the Board of Directors of TSO3. Mr. Lamarre contributed sound and constructive counsel on TSO3's Board of Directors, and while leading TSO3's Human Resources Committee. Mr. Lamarre was a pillar of the Canadian business community, holding several board positions, including the position of Board Chair for SEMAFO, and various other positions of significant responsibility with Groupe Lavalin and numerous other organizations.
"We are deeply saddened by the passing of our friend and colleague Jean Lamarre," said Ric Rumble, TSO3's President and Chief Executive Officer. "Jean always stressed that it is the people that make up a business, not just the technology. Through his leadership experience, broad business expertise and insights, Jean contributed greatly to TSO3, and he will be sorely missed. Our thoughts and prayers are with his family and friends."
Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
For more information about TSO3, visit the Company's website at www.tso3.com.
SOURCE TSO3 Inc.
For further information: Company Contacts: R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: email@example.com; Glen Kayll, CFO, Tel: 418 651-0003, Email: firstname.lastname@example.org; Investor Relations: Gilmartin Group, Greg Chodaczek, Tel: 610-368-6505, Email: Greg@gilmartinir.com; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, Email: email@example.com
About TSO3TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used...